# Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia

> **NCT00303823** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 98 (actual)

## Conditions studied

- Cervical Cancer
- Cervical Intraepithelial Neoplasia Grade 1
- Human Papilloma Virus Infection

## Interventions

- **DRUG:** placebo
- **DIETARY_SUPPLEMENT:** defined green tea catechin extract
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00303823
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2010-11
- **Final completion:** 2011-02
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2015-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00303823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00303823, "Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00303823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*